TyraTech Inc. (AIM: TYR), a natural life sciences company that harnesses the power of nature to improve human and animal health using a proprietary, novel technology that is both effective against insects and parasites and safe for people and pets, today announces that its Annual Report and Accounts for the year ended 31 December 2010 is being mailed to shareholders and is available on its website www.tyratech.com.
For further details please contact:
Tyratech, Inc.
Alan Reade, Executive Chairman Tel: +1 919 415 4310
Peter Jerome, Chief Financial Officer Tel: +1 919 415 4280
Brewin Dolphin Limited, Nominated Adviser
Matthew Davis Tel: +44 207 248 4400
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.